06 - 07 December - Paris, Hotel Pullman Montparnasse France
PractitionersTo gain a better understanding of the results of recent major trials and their impact on clinical practice.
AcademicsTo engage with practitioners and other stakeholders on the relevance of ongoing research and future trials.
Young TrialistTo learn and network with senior KOLs in order to help shape your future practice and career. Grants are available to young trialists! For more information go to the "Young Investigator Grants" section.
R&D Teams from pharmaceutical and device companiesTo present and discuss current research and future trials with scientific and regulatory professionals.
Since 2010, CVCT Forum offers grant specifically for young clinical trialists interested in learning more about the most up-to-date trials in cardiovascular disease.
The Grant: one full scientific registration to attend CVCT 2013 in Paris (including congress materials, lunches and coffee breaks) as well as two nights’ hotel accommodation and a travel grant of up to 200 €.Apply now for the new CVCT 2013 Young Clinical Trialists Grant Special rates for the Working Group membersMembers of the Working Group on Cardiovascular Pharmacology and Drug Therapy can benefit for special registration fees.Register from here and save up 300€.Not member yet ? Become a member and save moneyInterview of Prof. Luis Ruilope
Apply now for the new CVCT 2013 Young Clinical Trialists Grant
Members of the Working Group on Cardiovascular Pharmacology and Drug Therapy can benefit for special registration fees.Register from here and save up 300€.
Not member yet ? Become a member and save money
“To me the advantage of CVCT Forum is that it is the only meeting in which you are updated with all the recently finished and ongoing trials,” he said. “Hot topics are debated and this makes quite a complete picture of cardiovascular disease in the sense of how it has to be treated. For people interested in cardiovascular disease CVCT Forum can easily update you on all the things that are relevant in two and a half days.”
Another reason Pr Ruilope keeps coming back to CVCT is for the networking possibilities. “This meeting has a double advantage,” he explained. “You have the official sessions within the meeting at which senior and junior investigators can sit around one table and discuss. But you also have the opportunity for corridor discussions. These informal conversations improve your knowledge of what others are doing that may not be in the program. "A stronger focus on the interaction "
“If you attend ESC you have the most complete information, of course, but that is a huge meeting. CVCT is specifically devoted to trials and those experts are more easily accessible than at a big meeting.”
The stimulating, interactive session format is what encourages Pr Ruilope to return to CVCT Forum and he is pleased to see the next wave of investigators and other members of the medical trial community so engaged with the meeting. “Young investigators today require imagination,” he said. “The pharmaceutical industry requires imagination, too, not only for new drugs but also for new trials that profile those drugs. If we sit down for an hour I can give you countless new ideas for trials but perhaps not one of them will become a reality. CVCT brings the funding institutions – both government and industry – to the place where they can meet the trialists and prepare together for work ahead.” Past meeting reports & recordings
7th CVCT Forum 2010 - Paris (FR)
6th CVCT Forum 2009 - Paris (FR)
5th CVCT Forum - Cannes (FR) 2008
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved